|
Originally published In Press as doi:10.1074/jbc.M104067200 on July 6, 2001
J. Biol. Chem., Vol. 276, Issue 36, 33588-33595, September 7, 2001
The Role of the Cysteine Residues of ThiI in the Generation
of 4-Thiouridine in tRNA*
Eugene G.
Mueller ,
Peter M.
Palenchar§, and
Christopher J.
Buck
From the Department of Chemistry and Biochemistry, the University
of Delaware, Newark, Delaware 19716
Received for publication, May 7, 2001, and in revised form, July 3, 2001
 |
ABSTRACT |
The enzyme ThiI is common to the
biosynthetic pathways leading to both thiamin and 4-thiouridine in
tRNA. We earlier noted the presence of a motif shared with
sulfurtransferases, and we reported that the cysteine residue (Cys-456
of Escherichia coli ThiI) found in this motif is essential
for activity (Palenchar, P. M., Buck, C. J., Cheng, H.,
Larson, T. J., and Mueller, E. G. (2000) J. Biol.
Chem. 275, 8283-8286). In light of that finding and the report
of the involvement of the protein IscS in the reaction (Kambampati, R.,
and Lauhon, C. T. (1999) Biochemistry 38, 16561-16568), we proposed two mechanisms for the sulfur transfer
mediated by ThiI, and both suggested possible involvement of the thiol
group of another cysteine residue in ThiI. We have now substituted each of the cysteine residues with alanine and characterized the effect on
activity in vivo and in vitro. Cys-108 and
Cys-202 were converted to alanine with no significant effect on ThiI
activity, and C207A ThiI was only mildly impaired. Substitution of
Cys-344, the only cysteine residue conserved among all sequenced ThiI,
resulted in the loss of function in vivo and a 2700-fold
reduction in activity measured in vitro. We also examined
the possibility that ThiI contains an iron-sulfur cluster or disulfide
bonds in the resting state, and we found no evidence to support the
presence of either species. We propose that Cys-344 forms a disulfide
bond with Cys-456 during turnover, and we present evidence that a
disulfide bond can form between these two residues in native ThiI and
that disulfide bonds do form in ThiI during turnover. We also discuss
the relevance of these findings to the biosynthesis of thiamin and
iron-sulfur clusters.
 |
INTRODUCTION |
The metabolism of many sulfur-containing biomolecules remains
incompletely understood. Among the metabolic pathways requiring further
elucidation are those leading to iron-sulfur clusters (1-5), biotin
(6-8), molybdopterin (9), lipoic acid (10), thiamin (8, 11), and
sulfur-containing bases in RNA (12). The sulfur-containing nucleosides
include 4-thiouridine
(s4U),1 which is
found at position 8 of some bacterial tRNA (Fig.
1) and serves as a photosensor for
near-UV light (12). The s4U undergoes a photoactivated 2 + 2 cycloaddition with cytidine 13 when the tRNA is exposed to light of a
wavelength similar to the 334 nm absorbance maximum of s4U
(13-15). The resulting cross-linked tRNA are poor aminoacylation substrates (16), and the accumulation of uncharged tRNA arrests growth
by triggering the stringent response (17, 18). Lipsett and co-workers
(19, 20) investigated the enzymology of s4U biosynthesis in
Escherichia coli and reported that the overall reaction
utilized cysteine as the sulfur donor and required ATP as a substrate.
Lipsett and co-workers (20) concluded that two enzymes were required
and that one of them also plays a role in thiamin biosynthesis and
requires the cofactor PLP for activity (21, 22). By using a genetic
screen based on the role of s4U as a photosensor (18,
22-24), the genetic loci of two genes required for s4U
biosynthesis (named nuvA and nuvC) were mapped
(22-24).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
4-Thiouridine in tRNA. A, the
overall reaction, which is catalyzed by sequential action of the
enzymes IscS and ThiI; cysteine, ATP, and uridine-8 of certain
bacterial tRNA are the substrates. B, the location of
s4U in bacterial tRNA; s4U occurs at position
8, which is shown by a filled circle in the
"cloverleaf" structure of tRNA.
|
|
By using the same genetic screen, we identified the gene
thiI as essential for s4U formation (25) shortly
after Downs and co-workers (26) identified the same gene as essential
for thiamin biosynthesis. We have cloned and overexpressed
thiI from E. coli (25). Kambampati and Lauhon (27) isolated another enzyme, IscS, that sufficed along with ThiI for
in vitro generation of s4U in tRNA, and they
have since confirmed (28) that
iscS mutants lack s4U and are thiamin
auxotrophs.2 IscS is a NifS-like protein that functions in
iron-sulfur cluster formation, is PLP-dependent, and
proceeds through an enzymic persulfide intermediate (29, 30). Based on
sequence alignments that revealed similarity between the segment of
ThiI around Cys-456 and other sulfurtransferases, we investigated the
importance of Cys-456 for the function of ThiI and found that C456A
ThiI was inactive both in vivo and in vitro (31).
The report of the role of IscS in s4U biosynthesis fit
nicely with our independent conclusion that ThiI would proceed through
a persulfide intermediate on Cys-456 by providing a source of
S0 to form that persulfide group. Since our report,
Kambampati and Lauhon (32) have established that sulfur flows from
cysteine to IscS to ThiI to s4U in tRNA.
Based on all the evidence, we proposed two alternative mechanisms for
the biosynthesis of s4U (Fig.
2), and both immediately suggest a role
for another cysteine residue in ThiI (31). E. coli ThiI has
four cysteine residues other than Cys-456, and sequence alignments of
known ThiI proteins (all from prokaryotes) reveal that only one
cysteine residue, Cys-344 in the E. coli enzyme, is
completely conserved,3
suggesting that this amino acid serves a critical role. We now report
that this supposition is borne out by our investigations of the role of
the cysteine residues in ThiI.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Proposed mechanisms for s4U
generation. Based on the data presented here, we now consider it
likely that Cys-344 of ThiI fulfills the role that we previously (31)
ascribed to an unspecified thiol group. A, mechanism
providing for the direct nucleophilic attack on an activated uridine
species by the terminal sulfur of the persulfide on Cys-456 of ThiI.
B, mechanism in which ThiI functions to generate hydrogen
sulfide, which subsequently serves as the nucleophile to displace the
activated oxygen of uridine 8. All events occur at an active site of
ThiI, and attachment of the cysteine residues to ThiI is denoted with a
squiggle. General acids are denoted as A, and
general bases are denoted as B; tRNA denotes the
rest of the tRNA molecule that contains the depicted uridine residue.
The activation of uridine by adenylation is postulated based on the
demonstrated importance of a sequence motif shared between ThiI and
enzymes that adenylate carbonyl oxygens to activate them for subsequent
nucleophilic attack (35) and by preliminary determinations that AMP is
a product of s4U generation (C. Buck, unpublished
observations).
|
|
 |
EXPERIMENTAL PROCEDURES |
General--
Unless otherwise stated, all materials were
purchased from either Sigma or Fisher and used as provided. Sephadex
G-10, Sephadex G-25 (DNA grade), and [35S]cysteine were
purchased from Amersham Pharmacia Biotech. Nuclease P1, dithiothreitol
(DTT), chloramphenicol, kanamycin, ATP, and Tris were purchased from
Roche Molecular Biochemicals. Wizard® Genomic DNA Purification and
pGEM®-T Easy Vector System II kits, E. coli JM109 cells,
calf intestinal alkaline phosphatase, and Taq DNA polymerase
were purchased from Promega Corp. (Madison, WI). Competent BLR(DE3)
pLysS cells and pET29b were purchased from Novagen (Madison, WI). The
thiI mutant E. coli VJS2890(DE3) contains a
kanamycin resistance cassette inserted within thiI (33). A
Higgins analytical CLIPEUS C18 5-µm column (50 × 4.6 mm) was
purchased from Bodman Industries (Aston, PA). The tRNA substrate was
the in vitro transcript of E. coli
tRNAPhe, and we described the preparation in detail
elsewhere (34). Ni-NTA superflow resin, QIAquick Gel Extraction kits,
and QIAprep Spin Miniprep kits were purchased from Qiagen (Chatsworth,
CA). A BioCad SPRINT perfusion chromatography system (PE Biosystems, Foster City, CA) was used for protein purification by chromatography over Poros 20 HS resin (PE Biosystems). Oligonucleotides
(OPC-purified grade) were purchased from The Great American Gene
Co. (Ramona, CA). QuikChangeTM site-directed mutagenesis
kits were purchased from Stratagene (La Jolla, CA), and a Robocycler
Gradient 96 Thermocycler (Stratagene) was used for the PCR component of
the site-directed mutagenesis. DNA sequencing was performed either at
the University of Delaware Cell Biology Core Facility using a Long
Readir 4200 DNA sequencer (Li-Cor, Inc., Lincoln, NE) or at the
Delaware Biotechnology Institute and University of Delaware Center for
Agricultural Biotechnology core facility using an ABI Prism model
377 DNA sequencer (PE Biosystems). The complete sequences of all
plasmids described in this publication are posted at
www.udel.edu/chem/mueller.
Generation, Overexpression, Purification, and Physical
Characterization of Altered ThiI--
To substitute cysteine residues
in ThiI with alanine, the QuikChangeTM mutagenesis protocol
was used with appropriate primers (Table I) as we described previously (34). All
of the ThiI variants described in this paper contain the
20-amino acid N-terminal His6 tag provided by pET15b, but
all amino acid positions are numbered in terms of native ThiI (with no
N-terminal His6 tag). The parent plasmid was pBH113S, which
has N49S thiI in pET15b; as described previously (31), this
N49S mutation arose spontaneously during propagation of pBH113, which
is wild-type thiI in pET15b (25). All of the ThiI variants
described here are N-terminally His6-tagged and have the
N49S change; for the sake of simplicity, we will refer to them as
"ThiI" (specified as either wild type or by the substituted
cysteine residue).
View this table:
[in this window]
[in a new window]
|
Table I
Primers for the site-directed mutagenesis of ThiI and the cloning and
corrective site-directed mutagenesis of IscS
The plasmids encoding altered ThiI are named in parentheses beneath the
amino acid change. The primers are broken into codons (upper primer) or
their complements (lower primer), and the changed bases are underlined.
The restriction sites specified by the primers for the cloning of
iscS are shown in italics.
|
|
The overexpression, purification, and storage of each altered ThiI was
accomplished using the methods that we have described in detail
elsewhere (35). Protein expression was induced by addition of
isopropyl- -D-thiogalactopyranoside to the growth medium,
and the cells were harvested 3 h later. Chromatography of cell
extracts over Ni-NTA resin yielded essentially homogeneous ThiI, which
was changed into appropriate buffer and used immediately or
precipitated by addition of solid ammonium sulfate (to nominal 75%
saturation) for storage at 4 °C. By using the methods that we have
described elsewhere (35), extinction coefficients at 280 nm were
determined, and far-UV CD spectra were recorded for each altered ThiI.
The generation, isolation, and properties of the C456A ThiI have been
described previously (31).
In Vivo Characterization of Altered ThiI--
The effect of
substituting the cysteine residues of ThiI on its activity in
vivo was assessed in two ways. First, the thiI mutant
VJS2890(DE3) was transformed with a plasmid encoding an altered ThiI,
and the transformants were subjected to near-UV screening. The
screening of cells producing each altered ThiI was performed twice,
except for the cells expressing C202A and C207A ThiI, which were
performed four times; qualitatively identical results were obtained in
every case. Second, the UV spectrum of tRNA isolated from saturated
cultures of the transformants was recorded and examined for the
characteristic peak due to s4U ( max ~334
nm). The procedures for both of these in vivo
characterizations have been described in detail elsewhere (25).
Assay for s4U Generation--
This assay is
essentially the one that we have described previously (31) except that
recombinant IscS·His6 was substituted for cell extracts.
The generation of s4U was monitored by following the
incorporation of 35S into s4U from
L-[35S]cysteine. A typical assay mixture (350 µl) was 50 mM Tris-HCl buffer, pH 8.5, containing ATP (4 mM), pyridoxal 5'-phosphate (40 µM),
magnesium chloride (5 mM), in vitro transcript
of E. coli tRNAPhe (20 µM),
L-[35S]cysteine (484 µM; 123 µCi/µmol), DTT (1 mM), IscS·His6 (4 nM), and ThiI (1 nM). For the C344A ThiI, the
assays contained higher concentrations of the proteins, 4.8 µM IscS·His6 and 1.2 µM C344A ThiI. Reactions were initiated by the addition of recombinant ThiI and
incubated at 37 °C. At various times, aliquots (100 µl) were
removed, and [35S]s4U was quantitated by the
method that we have described in detail elsewhere (31). In this method,
unreacted L-[35S]cysteine is removed by
size-exclusion chromatography, and the tRNA is digested to nucleosides,
which are resolved by reverse phase high pressure liquid chromatography
(36, 37); the level of 35S in the s4U is
determined by in-line scintillation counting.
Cloning of IscS--
Genomic DNA was purified from E. coli JM109 cells (Promega) using the Wizard Genomic DNA
Purification protocol (Promega) according to the manufacturer's
instructions. PCR amplification of iscS in the genomic DNA
was achieved using appropriate primers (Table I), Taq DNA
polymerase (Promega), and HotStart tubes (Molecular Bio-Products Inc.,
San Diego) according to the HotStart protocol. The primers (Table I)
specified an NdeI site that includes the start ATG of
iscS and an EcoRI site that follows the TAA that terminates iscS. A Robocyler Gradient 96 thermal cycler
(Stratagene) was used for the PCR, as described elsewhere (25). The PCR
product was purified by agarose gel electrophoresis and recovered using the QIAquick gel extraction protocol (Qiagen). The isolated PCR product
was ligated into pGEM-T using the pGEM-T Easy Vector System II
(Promega) as specified by the manufacturer, and restriction analysis
confirmed the generation of the target plasmid. This plasmid was
digested with NdeI and EcoRI (New England
Biolabs, Beverly, MA), and the iscS fragment was isolated by
agarose gel electrophoresis and ligated into pET29b (Novagen) that had
been opened with the same enzymes. The success of the construction was
confirmed by restriction analysis, and the plasmid was named pBH400.
Sequencing of iscS in pBH400 revealed two discrepancies from
the published sequence as follows: a T C transition in codon 244 that results in the substitution of proline for leucine and a deletion
of the T in the penultimate codon that moves the stop codon specified
by the "reverse" PCR primer out of frame and brings the C-terminal
His6 tag encoded by pET29b into frame. IscS bearing the
C-terminal His6 tag will be denoted
IscS·His6. Both alterations of iscS in pBH400
were corrected using the QuikChangeTM protocol (Stratagene)
with appropriate primers (Table I) as we have described previously
(34). The plasmid encoding L244P IscS (with no C-terminal
His6 tag) is pBH401; the plasmid encoding IscS·His6 (with Leu-244 restored) is pBH402; the plasmid
encoding native IscS (with Leu-244 restored and no C-terminal
His6 tag) is pBH403.
Overexpression and Purification of
IscS·His6--
The procedure for overexpression and
purification of IscS·His6 and L244P
IscS·His6 was identical to that for the overexpression and purification of ThiI (35) except that cultures of BLR(DE3) pLysS/pBH402 or BLR(DE3) pLysS/pBH400 were grown and induced in LB
medium containing kanamycin (30 µg/ml) and chloramphenicol (34 µg/ml). Isolated IscS·His6 (~40 mg/liter of culture)
was dialyzed against 50 mM potassium phosphate buffer, pH
7.5, containing magnesium chloride (5 mM), potassium
chloride (100 mM), and EDTA (0.1 mM). The
enzyme remains stable for weeks to months when stored at 4 °C in the
same buffer at moderate concentration (3-4 mg/ml). By comparing
A280 nm and the concentration of IscS measured by the biuret assay (35), we calculated 280 nm = 25,400 M 1 cm 1, which we now use to
determine the concentration of IscS·His6.
Joint Overexpression of ThiI and IscS--
BLR(DE3) pLysS/pBH402
(encoding IscS·His6) and BLR(DE3) pLysS/pBH403 (encoding
native IscS) was transformed with pBH113 (encoding wild-type ThiI)
using the TransformAidTM protocol (MBI Fermentas, Hanover,
MD). The joint overexpression of ThiI and IscS was accomplished as
described for the overexpression of either protein alone. ThiI
overexpressed with native IscS was cleanly separated from the latter by
chromatography over Ni-NTA resin. ThiI overexpressed with
IscS·His6 was co-purified with the latter by
chromatography over Ni-NTA resin; the two proteins were then
separated by chromatography over Poros 20 HS resin, eluting with a
linear gradient (over 13 column volumes) of potassium chloride (0-1.5
M) in 50 mM potassium phosphate buffer, pH 7.5, containing DTT (1 mM). The UV-visible spectrum was recorded
after exchange of isolated ThiI into 50 mM potassium
phosphate buffer, pH 7.5, containing magnesium chloride (5 mM), potassium chloride (100 mM), and EDTA (0.1 mM) by size-exclusion chromatography over a spin column of
Sephadex G-25 equilibrated in the same buffer.
DTNB Titrations--
Samples of ThiI were subjected to DTNB
titrations under both native and denaturing conditions. The enzyme
samples were fresh preparations that had been isolated using buffers to
which no reductant had been added. Any thiol-bearing components of the cell extracts (either small or macro-molecules) should have been removed by the chromatography over Ni-NTA and the exchange (by size-exclusion chromatography or dialysis) of ThiI-bearing column fractions into 50 mM potassium phosphate buffer, pH 7.5, containing magnesium chloride (5 mM), potassium chloride
(100 mM), and EDTA (0.1 mM). The protein
concentration ranged from 4.7 to 16.6 µM, and DTNB (20 eq
relative to ThiI) was added as a solution (10 mM) in the
same buffer. Control incubations were prepared by adding the same
amount of DTNB to the same buffer (with no protein). The final mixtures
(400 µl) were incubated 20-30 min at room temperature, and the
intensely yellow dianion of 5-thio-2-nitrobenzoic acid was quantified
by subtracting the A412 nm of the control incubation from the A412 nm of each sample and
using an extinction coefficient of 13,600 M 1
cm 1 (38). To denature the wild-type ThiI, solid
guanidinium chloride (~0.23 g, ~2.4 mmol) was added to the samples
and dissolved to achieve a final guanidinium concentration of ~4.6
M; the volume and A412 nm values
were measured after 20 min at room temperature. All titrations were
performed in duplicate except for the C456A ThiI under native
conditions, which was performed in quadruplicate. Titrations of ThiI
with 1 eq of DTNB were performed under native conditions as described
for titration with 20 eq of DTNB. All replicate experiments returned
values within 5% of each other.
Assay for Disulfide Bond Formation during Turnover--
To test
for disulfide bond formation in ThiI during turnover, the
s4U generation assay was run without DTT, with a reduced
concentration of cysteine (which can reduce disulfide bonds), and in
phosphate buffer to allow separation of IscS and ThiI by
cation-exchange chromatography. The assay (1 ml) consisted of 150 mM potassium phosphate buffer, pH 8.5, containing ATP (4 mM), PLP (40 µM), tRNA (18 µM),
cysteine (70 µM), IscS (24 µM), and ThiI (6 µM). After 5 h at 37 °C, ThiI was separated from
IscS and other reaction components by chromatography over Poros 20 HS
resin as described above except that DTT was omitted from the buffers.
The ThiI eluted in two fractions, which were combined (1 ml; 2-3
µM), concentrated in a Microcon-10 device, and subjected
to DTNB titrations under denaturing conditions as described above. As a
control for oxidation under these conditions, ThiI was also incubated
in the absence of tRNA and cysteine and subjected to the same work up.
To measure the extent of s4U formation under these
conditions, a duplicate reaction containing [35S]cysteine
was run in parallel; 0.73 ± 0.02 eq (relative to ThiI) of
s4U was generated. Assuming that turnover results in the
formation of one disulfide bond in ThiI, the expected number of free
thiol groups in ThiI isolated after turnover is (0.73) (3 thiol
groups) + (0.27) (5 thiol groups) = 3.5 thiol groups.
 |
RESULTS |
Cloning and Overexpression of IscS--
The PCR-based cloning of
iscS from E. coli genomic DNA resulted in the
generation of an IscS overexpression plasmid based on pET29b (pBH400).
Sequencing revealed a deletion in the penultimate codon of
iscS during the PCR, resulting in a frameshift that fused a
C-terminal His6 tag to IscS (denoted
IscS·His6). In addition, a proline residue was encoded by
codon 244 rather than the leucine specified by the sequence in the
genomic data base. Overexpressed and purified L244P
IscS·His6 proved fully competent for in vitro assay of ThiI activity. Site-directed mutagenesis was used to generate
overexpression plasmids for IscS with Leu-244 restored (pBH402) and
with both Leu-244 and the penultimate codon restored (pBH403), which
brings the stop codon back into frame and eliminates the C-terminal
His6 tag. IscS·His6 and L244P
IscS·His6 behaved identically in our assays of ThiI
activity; since they are easily purified, we used them in preference to
native IscS (L244P IscS·His6 was used in earlier
experiments, and IscS·His6 was used in later experiments).
Generation, Overexpression, and Physical Characterization of
Altered ThiI--
Site-directed mutagenesis afforded ThiI with each
cysteine residue singly changed to alanine. All of the ThiI variants
discussed below also contain a serine in place of the wild-type Asn-49. We discovered this mutation only after the generation of the
altered ThiI, and we determined that the N49S ThiI is insignificantly (15-20%) more active than the wild-type enzyme (with
Asn-49) in our current assay system. We did not restore Asn-49 in each
of the variant ThiI, for the existing protein context provided an internally consistent evaluation of the effects of altering the cysteine residues. ThiI variants with one cysteine residue replaced with alanine were identical to wild-type ThiI regarding overexpression, purification, and storage. Extinction coefficients at 280 nm were determined for each altered ThiI, and they varied less than 5% from
that of wild-type enzyme (63,100 M 1
cm 1) as follows: C108A, 64,500 M 1 cm 1; C202A, 64,000 M 1 cm 1; C207A, 66,000 M 1 cm 1; C344A, 63,900 M 1 cm 1. The far-UV CD spectrum
of each altered ThiI was essentially identical to the spectrum of
wild-type enzyme (data not shown). Together, these data indicate that
the substitutions of alanine for cysteine did not disrupt the global
protein fold.
In Vivo Characterization of Altered ThiI--
The thiI
mutant E. coli VJS2890(DE3) (33) was transformed with
plasmids expressing wild-type and altered ThiI, and the transformants were screened for near-UV sensitivity. VJS2890(DE3) is
near-UV-resistant because it lacks a functional thiI and so
fails to generate s4U in tRNA (the photosensor).
VJS2890(DE3) was fully complemented by plasmids encoding wild-type,
C108A, and C202A4 ThiI, but
VJS2890(DE3) harboring the plasmid encoding C344A ThiI retained the
near-UV-resistant phenotype. The plasmid encoding C207A ThiI conferred
an intermediate phenotype; only one-third to one-half the number of
colonies appeared on the near-UV-exposed side as appeared on the masked
side of the plate, and all of the colonies on the exposed side were
very small; after 24 h further incubation in the dark, both sides
of the selection plate were indistinguishable regarding colony number
and size.5 The UV-visible
spectra were recorded for tRNA isolated from VJS2890(DE3) harboring
plasmids encoding wild-type and altered ThiI (Fig.
3). The levels of s4U in tRNA
correlate well with the selection results, with little or no
s4U indicated in the tRNA from VJS2890(DE3) expressing
C344A ThiI and a reduced amount of s4U in the tRNA from
VJS2890(DE3) expressing C207A ThiI.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
UV-visible spectra of tRNA isolated from the
thiI mutant VJS2890(DE3) expressing either wild-type
or altered ThiI. The tRNA was present at equal concentrations in
all samples, as judged from A260 nm = 52 for
each. The ThiI variant expressed in the cells from which the tRNA was
isolated are denoted as follows: ---, wild-type; - - - -,
C108A; · · · , C202A; --- · ---·, C207A,
--- - ---, C344A.
|
|
Activity Assays--
The assay procedure was changed from our
previous report (31) by inclusion of purified IscS·His6
rather than cell extracts. A molar ratio of 4:1
IscS·His6:ThiI was used in the assays because it affords
a linear response in rate when the concentration of ThiI is varied, and
additional IscS·His6 does not increase the reaction rate.
No s4U generation was observed when ThiI was omitted from
the reaction mixture, even with elevated concentrations of
IscS·His6 (4.8 µM). The rates of
s4U formation catalyzed by wild-type, C108A, and C202A ThiI
did not differ appreciably. C207A ThiI displayed a 4-fold reduction in
rate, and C344A ThiI was impaired for s4U generation by
2700-fold (Fig. 4 and Table
II). C456A ThiI (31) was re-examined in
the assay system containing purified IscS·His6 rather
than cell extracts, and no s4U generation was detected even
at elevated concentrations of C456A ThiI (1.2 µM) and
IscS·His6 (4.8 µM) and prolonged incubation times (90 min). Together, the measured activities of IscS alone and the
C344A and C456A ThiI make it unlikely that the activity of C344A ThiI
is due to contamination with wild-type enzyme expressed from the host
cell genome.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Generation of s4U in the activity
assay for ThiI. One representative run is shown for each ThiI
variant; the data shown here was used along with duplicate runs to
generate the data in Table II. The ThiI variants are denoted:
, wild-type; , C108A; , C202A; , C207A; ×, C344A.
All of the variants were present at a concentration of 1 nM
in the assay except for C344A ThiI, which was present at 1.2 µM.
|
|
Joint Overexpression of ThiI and IscS--
BLR(DE3) pLysS cells
harboring pBH113 (encoding wild-type ThiI) and either pBH402 (encoding
IscS·His6) or pBH403 (encoding native IscS) were
generated. Induction of both types of cells with
isopropyl- -D-thiogalactopyranoside resulted in
overexpression of both IscS and ThiI, with IscS present at roughly
4-fold greater concentration than ThiI as determined by
SDS-polyacrylamide gel electrophoresis analysis. ThiI co-overexpressed
with both variants of IscS was isolated, and their UV-visible spectra
were recorded. Only the absorbance centered near 280 nm expected for
polypeptides was observed; no spectroscopic features indicative of
iron-sulfur clusters (or any other cofactor) were present.
Quantitation of Thiol Groups in ThiI--
Under denaturing
conditions (~4.6 M guanidinium chloride), DTNB titrations
revealed 5.1 ± 0.2 free thiol groups in wild-type ThiI. Under
native conditions, DTNB titrations revealed 3.9 ± 0.3 and
3.3 ± 0.3 reactive thiol groups, respectively, in wild-type and
C344A ThiI. The variation from integral values is within the uncertainty of the method. To determine whether or not a disulfide bond
forms during turnover, ThiI was isolated after s4U
generation in the absence of an exogenous reductant other than the
substrate cysteine. DTNB titrations under denaturing conditions revealed 4.1 ± 0.3 free thiol groups in ThiI (determined in
triplicate). A parallel assay (performed in quadruplicate) of
s4U generation showed that 73% of ThiI turned over under
these reaction conditions, so 3.5 free thiol groups were expected.
Although the observed 4.1 free thiol group is significantly higher than
the expected value, this discrepancy likely arises from the obligatory presence of cysteine, which can reduce disulfide bonds. As a control for oxidation unrelated to catalytic activity, ThiI was incubated under
identical conditions except that cysteine and tRNA were omitted. DTNB
titrations under denaturing conditions of the isolated ThiI revealed
4.9 ± 0.2 thiol groups (determined in triplicate), demonstrating
that s4U generation significantly decreased the number of
free thiol groups in ThiI, consistent with the formation of a disulfide
bond during turnover.
Evidence of a Disulfide Bond between Cys-344 and
Cys-456--
To test whether or not Cys-344 and Cys-456 can form a
disulfide bond, titrations of ThiI with 1 eq of DTNB were performed; if
a disulfide bond forms, then one expects 2 eq of the chromophore 5-thio-2-nitrobenzoate to be released. DTNB will first react with the
free thiol group of one cysteine residue to release 1 eq of chromophore
and form a mixed disulfide between the cysteine residue and "half"
of DTNB. A second cysteine residue can then displace another equivalent
of chromophore to form the purely enzymic disulfide. When wild-type
ThiI was treated with 1 eq of DTNB, 1.8 ± 0.2 eq of chromophore
were produced. With C456A ThiI, 1.3 ± 0.2 eq of chromophore were
generated, whereas 0.9 ± 0.1 eq of chromophore resulted from
treatment of C344A ThiI with 1 eq of DTNB. ThiI, then, can readily form
a disulfide bond unless either Cys-344 or Cys-456 is replaced with
alanine, which is most simply explained by a disulfide bond between
Cys-344 and Cys-456.
 |
DISCUSSION |
Based on sequence alignments with sulfurtransferases, we
previously investigated (31) the role of Cys-456 of ThiI in the biosynthesis of s4U and found that residue to be essential.
The catalytically essential Cys-456 is found on a C-terminal extension
of ~100 amino acids that was then found only in ThiI from E. coli and its close relatives Salmonella typhimurium and
Hemophilus influenzae among the organisms for which a ThiI
sequence was known (31). Currently, sequences of ThiI from 23 organisms
(all prokaryotes) are known, and 8 have the C-terminal
extension.3 Some of the bacteria with the shorter ThiI have
open reading frames that are highly similar to the C-terminal extension
found in the E. coli ThiI3, which suggests that
this C-terminal extension may function as an autonomous
sulfurtransferase domain. Consistent with our proposed domain
structure, Kambampati and Lauhon (32) report that light trypsinolysis
cleaves ThiI into two major fragments, the larger of which is inactive
for sulfur transfer and of a size (Mr ~45, 000) consistent with our postulated N-terminal domain.
Our findings concerning Cys-456 coupled with the report of Kambampati
and Lauhon (27) that IscS was involved in s4U biosynthesis
led us to offer two mechanisms for s4U biosynthesis (Fig.
2). The key features of these two mechanisms are formation of a
persulfide on Cys-456 by trans-persulfidation at the expense of the
persulfide on IscS and the liberation of the terminal sulfur of the
Cys-456 persulfide as a formal equivalent of S2- rather
than S0. Subsequently, Kambampati and Lauhon (32) confirmed
the transfer of sulfur from free cysteine to IscS to ThiI to tRNA,
which led those authors to propose (independently of our results) a
sulfur transfer scheme that is similar to our mechanisms although less detailed. Our mechanisms (Fig. 2) both postulate the participation of a
thiol group to liberate the formal S2- equivalent (in
s4U itself or as hydrogen sulfide), which immediately
suggests the possible participation by another enzymic cysteine
residue. As observed by us3 and Kambampati and Lauhon (32),
sequence alignments reveal that only Cys-344 is absolutely conserved
among all ThiI for which sequences are known. To test the role of the
conserved Cys-344 and the other three cysteine residues, we separately
substituted each one with alanine in E. coli ThiI and
measured the effect on ThiI function both in vivo and
in vitro.
All of the altered ThiI appear to maintain the global fold
of wild-type enzyme as judged by overexpression and storage behavior, extinction coefficients, and far-UV CD spectra that do not vary significantly from those of wild-type ThiI. The substitution of Cys-108
and Cys-202 had negligible effects on the measured activity of ThiI
both in vivo (Fig. 3) and in vitro (Table II). In
agreement with the prediction from sequence alignments, Cys-344 proved
critical for ThiI activity both in vivo (Fig. 3) and
in vitro (Table II), although C344A ThiI retains some
activity under our assay conditions. C207A ThiI is an intermediate
case, impaired but functional in vivo (Fig. 3) and in
vitro (Table II). This mild effect on activity could arise from a
local conformational change upon substitution of Cys-207 that does not
significantly perturb the solution behavior or CD spectrum. These
findings, however, are also consistent with a more direct role for
Cys-207 in s4U generation that is either nonessential or
may be assumed by some other component in the cell or the assay
mixture. In either case, detailed kinetic studies, a structure, or
both will be required to determine the role of Cys-207.
We are left, then, with a need to accommodate a critical
but not absolute role for Cys-344. One explanation for the roles of
IscS and the cysteine residues in ThiI would be formation of an
iron-sulfur cluster in ThiI (IscS (29) was named for its role in
iron-sulfur cluster formation). The
hypothetical ThiI iron-sulfur cluster might serve as an intermediate in
the transfer of sulfur from free cysteine to tRNA, similar to the
proposals for biotin (6, 7) and lipoic acid biosynthesis (10). In this
case, a small amount of iron-sulfur cluster would be generated in the
assay mixture, producing highly active ThiI. No evidence has been
presented to suggest that ThiI bears such a cluster, but only
overexpressed ThiI has been examined, leaving open the possibility that
the high level of ThiI in the overexpression cells swamps the capacity
to generate iron-sulfur clusters. Although we did not consider the
requirement of an iron-sulfur cluster likely, the experiment was
straightforward: we overexpressed IscS and ThiI in the same cells. Even
though IscS was present at roughly 4-fold higher concentration than
ThiI, isolated ThiI displays no spectroscopic evidence of an
iron-sulfur cluster (or any other cofactor).
The main premise that led us to undertake the substitution of each
cysteine with alanine was that an enzymic disulfide bond might form
during catalysis (Fig. 2). Because the resting state of ThiI could be
the form with the disulfide bond, we titrated the wild-type enzyme with
DTNB in the presence of guanidinium chloride, and the denatured
wild-type ThiI showed 5 thiol groups. Since ThiI has five cysteine
residues, we conclude that ThiI is fully reduced in its resting state
(at least in cells that overexpress it).
By having ruled out a disulfide bond in resting ThiI, we sought
evidence that a disulfide bond forms during turnover. If true, omitting
reductant would limit the enzyme to a single turnover, for the ThiI
would be left in the inactive disulfide-bonded state. Quantitation of
the s4U formed and titration of free thiol groups in the
resultant ThiI would allow assessment of the proposed disulfide bond.
In practice, the substrate cysteine is also a reductant for disulfide
bonds, so we are hampered in attaining the desired single turnover
conditions. We proceeded by omitting DTT from the assay mixture and
lowering the concentration of cysteine. Under these conditions, less
than 1 eq of s4U was formed relative to ThiI, supporting
the need for exogenous reductant for multiple turnovers. Titration of
ThiI isolated from the reaction mixture revealed fewer thiol groups
than before the reaction. Both results are in agreement with disulfide
bond formation during turnover, but does the disulfide bond form
between Cys-456 and Cys-344? Titration of native, wild-type ThiI with 1 eq of DTNB produced 2 eq of the thiolate product
5-thio-2-nitrobenzoate, which requires formation of a disulfide bond on
ThiI. When C456A and C344A ThiI were subjected to titration with 1 eq
of DTNB, only 1 eq of the thiolate product formed (the other "half"
of DTNB was left as a mixed disulfide with ThiI). The simplest
explanation of these results is formation of a disulfide bond between
Cys-456 and Cys-344.
The profoundly reduced activity of C344A ThiI (2700-fold, Table II) is
also consistent with formation of a disulfide bond between Cys-456 and
Cys-344 during turnover. But if this catalytically critical disulfide
bond exists, why does C344A ThiI display residual activity? If the side
chain of Cys-344 were surface-accessible, a thiol group from an
exogenous molecule (such as DTT in the assay mixture) might substitute,
albeit inefficiently, for the missing thiol group in C344A ThiI. To
probe this possibility, we compared the reactivity of wild-type and
C344A ThiI toward DTNB in the absence of denaturant.
Wild-type ThiI registered 4 thiol groups, and C344A ThiI registered 3. These results indicate that the side chains of Cys-344 is among the
four (of five) cysteine side chains in ThiI that appear to be
surface-accessible, which supports the residual in vitro
activity of C344A ThiI arising from rescue by thiol groups of DTT. All
of our results, then, are consistent with our hypothesis that Cys-344
forms a disulfide bond with Cys-456 during turnover of ThiI (Fig.
2).
We now consider the extrapolation of our results and proposals to the
biosynthesis of other sulfur-containing molecules. Our mechanistic
possibilities accommodate the dual function of ThiI in s4U
and thiamin biosynthesis, especially considering the evidence that the
C terminus of E. coli ThiI constitutes a sulfurtransferase domain of ~100 amino acids that may behave nearly independently from
the N-terminal portion of ThiI (31). The persulfide on Cys-456, then,
would serve as a nucleophile at either another active site on ThiI to
make the tRNA-disulfide intermediate (Fig. 2A) or at an
active site in the complex of the proteins ThiF and ThiS to form a
disulfide intermediate on the way to the thiocarboxylate of ThiS, which
is the ultimate sulfur donor for thiamin biosynthesis (33). If the
C-terminal domain of ThiI constitutes a hydrogen sulfide-generating
domain (Fig. 2B), the dual role of ThiI in s4U
and thiamin biosynthesis is also readily accommodated; the hydrogen sulfide is shunted either toward the activated uridine in tRNA in
another ThiI-active site or toward the adenylate of the terminal carboxylate of ThiS in an active site in the ThiF-ThiS complex. This
latter possibility is attractive in light of the reports by both the
groups of Begley et al. (11) and Lauhon and Kambampati (28)
that ThiI stimulates but is not required for the production of the ThiS
thiocarboxylate in vitro; hydrogen sulfide is generated slowly by IscS (27, 29), which would allow thiocarboxylate formation in
the absence of ThiI. Furthermore, Lauhon and Kambampati (28) report
that inorganic sulfide (at 5 mM) can substitute for IscS
and cysteine in the in vitro generation of the
thiocarboxylate of ThiS, and those authors also raise hydrogen sulfide
generation as a likely role for ThiI. However, the absence of
detectable activity by C456A ThiI must be accommodated because IscS
should suffice if the postulated C-terminal domain of ThiI serves only to generate hydrogen sulfide. Scenarios such as an activating conformational change triggered by the formation of the Cys-456 persulfide can account for the observations, but these issues clearly
require further investigation.
A mechanism of hydrogen sulfide generation similar to the one we
propose (Fig. 2B) may also operate in the generation of
iron-sulfur clusters. IscS would again serve as an S0 donor
to make a persulfide group on another protein, which could be a
scaffold protein such as NifU (4) or IscU (3, 5) or a protein that
bears a permanent iron-sulfur cluster. The enzymic persulfide then
would undergo nucleophilic attack by another cysteine residue to make
an enzymic disulfide bond and liberate sulfide for the assembling
cluster. The cysteine side chains would be regenerated as thiol groups
when the disulfide is reduced, likely by a thioredoxin/thioredoxin
reductase or glutathione/glutaredoxin pair. Two cysteine residues in
the iron-sulfur cluster proteins could be dedicated to sulfide
generation, or cysteine residues that serve as ligands for iron could
undergo this chemistry. If the cluster ligands are used, the process
could repeat until all but one cysteine residue was bound to iron in
the incipient cluster. It follows naturally from this scenario that the
last sulfide in the cluster is generated from the last cysteine
persulfide, and the final step of cluster formation would therefore be
the reductive cleavage of the persulfide group to generate the last sulfide and the final cysteine ligand. Intriguingly, when clusters are
assembled in vitro using cysteine and IscS or NifS to
provide sulfide, the initial cluster is oxidized by two electrons
relative to the iron(II) used in assembly (3-5). This cluster
oxidation state is expected from reductive cleavage of the persulfide
group. Our proposal for sulfide delivery to growing iron-sulfur
clusters is chemically reasonable and consistent with current reports
of cluster generation, and we offer it to encourage further experiments.
The studies presented here along with our previous report concerning
the essential role of Cys-456 (31) provide a solid framework for
understanding the nature of sulfur transfer from cysteine through IscS
and ThiI to tRNA. ThiI contains neither an iron-sulfur cluster nor a
disulfide bond in its resting state. In the absence of reductants, ThiI
supports s4U generation but cannot achieve more than one
turnover and suffers a loss of thiol groups. All of the evidence
supports the formation of a disulfide bond between Cys-456 and Cys-344
during turnover, and indirect evidence strongly suggests that this
disulfide bond forms readily in native ThiI. Since the disulfide bond
between Cys-456 and Cys-344 is a feature of both of our proposed
mechanisms (Fig. 2), we cannot yet exclude nor favor one or the other,
but we have already begun studies that should allow us to do so.
 |
Note Added in Proof |
Begley and co-workers (40) have recently
reported an acyldisulfide linkage between the C terminus of ThiS and
Cys-184 of ThiF and propose that this species rather than the
thiocarboxylate of ThiS is the true intermediate in thiamin
biosynthesis. While this finding clouds the involvement of ThiI in
thiamin biosynthesis, it does provide a gratifying example of a
nucleophilic attack by an enzymic persulfide group, which was
unprecedented when we offered the first mechanism proposing such an
event (31).
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant GM59636.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Chemistry and
Biochemistry, University of Delaware, Newark, DE 19716. Tel.:
302-831-2739; Fax: 302-831-6335; E-mail: emueller@udel.edu; www.udel.edu/chem/mueller.
§
Supported in part by United States Public Health Service Grant T32 GM08550.
Published, JBC Papers in Press, July 6, 2001, DOI 10.1074/jbc.M104067200
2
The congruence of nuvA and
nuvC to thiI and iscS remains unclear
due to several apparent discrepancies between the chromosomal locations
of the genes and the phenotypes of nuvA and nuvC
mutants relative to thiI and iscS mutants.
3
P. Palenchar and E. Mueller, unpublished observations.
4
VJS2890(DE3) expressing C202A ThiI appears to
become inviable more quickly than the same cells expressing other ThiI
variants when stored at 4 °C on LB agar containing kanamycin and
carbenicillin. This conclusion is based on the repeated observation
that a much lower degree of dilution of a resuspended colony is
required to generate the same colony density on a selection plate as
compared to VJS2890(DE3) expressing other ThiI variants. We can offer
no rational explanation for this behavior in light of the essentially wild-type character of C202A ThiI in every other regard.
5
We have observed a similar phenotype with K321R
thiI (35) and rationalized it on the basis of stochastic
differential expression from the same promoter in different colonies,
consistent with the findings of Siegele and Hu (39).
 |
ABBREVIATIONS |
The abbreviations used are:
s4U, 4-thiouridine;
PLP, pyridoxal 5'-phosphate;
DTT, dithiothreitol;
DTNB, 5,5'-dithiobis(2-nitrobenzoic acid) (Ellman's reagent);
IscS·His6, IscS bearing the C-terminal His6
tag encoded by pET29b;
PCR, polymerase chain reaction;
Ni-NTA, nickel-nitrilotriacetic acid.
 |
REFERENCES |
| 1.
|
Zheng, L. M.,
Cash, V. L.,
Flint, D. H.,
and Dean, D. R.
(1998)
J. Biol. Chem.
273,
13264-13272
|
| 2.
|
Agar, J. N.,
Yuvaniyama, D.,
Dean, D. R.,
and Johnson, M. K.
(1999)
J. Inorg. Biochem.
74,
61
|
| 3.
|
Agar, J. N.,
Zheng, L. M.,
Cash, V. L.,
Dean, D. R.,
and Johnson, M. K.
(2000)
J. Am. Chem. Soc.
122,
2136-2137
|
| 4.
|
Yuvaniyama, P.,
Agar, J. N.,
Cash, V. L.,
Johnson, M. K.,
and Dean, D. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
599-604
|
| 5.
|
Agar, J. N.,
Krebs, C.,
Frazzon, J.,
Huynh, B. H.,
Dean, D. R.,
and Johnson, M. K.
(2000)
Biochemistry
39,
7856-7862
|
| 6.
|
Bui, B. T. S.,
Florentin, D.,
Fournier, F.,
Ploux, O.,
Mejean, A.,
and Marquet, A.
(1998)
FEBS Lett.
440,
226-230
|
| 7.
|
Gibson, K. J.,
Pelletier, D. A.,
and Turner, I. M.
(1999)
Biochem. Biophys. Res. Commun.
254,
632-635
|
| 8.
|
Begley, T. P.,
Xi, J.,
Kinsland, C.,
Taylor, S.,
and McLafferty, F.
(1999)
Curr. Opin. Chem. Biol.
3,
623-629
|
| 9.
|
Rajagopalan, K. V.
(1997)
Biochem. Soc. Trans.
25,
757-761
|
| 10.
|
Ollagnier-de Choudens, S.,
and Fontecave, M.
(1999)
FEBS Lett.
453,
25-28
|
| 11.
|
Begley, T. P.,
Downs, D. M.,
Ealick, S. E.,
McLafferty, F. W.,
Van Loon, A.,
Taylor, S.,
Campobasso, N.,
Chiu, H. J.,
Kinsland, C.,
Reddick, J. J.,
and Xi, J.
(1999)
Arch. Microbiol.
171,
293-300
|
| 12.
|
Grosjean, H.,
and Benne, R.
(1998)
Modification and Editing of RNA
, American Society for Microbiology, Washington, D. C.
|
| 13.
|
Favre, A.,
Yaniv, M.,
and Michelson, A. M.
(1969)
Biochem. Biophys. Res. Commun.
37,
266-271
|
| 14.
|
Bergstrom, D. E.,
and Leonard, N. J.
(1971)
Biochemistry
11,
1-9
|
| 15.
|
Favre, A.,
Michelson, A. M.,
and Yaniv, M.
(1971)
J. Mol. Biol.
58,
367-379
|
| 16.
|
Carre, D. S.,
Thomas, G.,
and Favre, A.
(1974)
Biochimie (Paris)
56,
1089-1101
|
| 17.
|
Ramabhadran, T. V.,
and Jagger, J.
(1976)
Proc. Natl. Acad. Sci. U. S. A.
73,
59-63
|
| 18.
|
Kramer, G. F.,
Baker, J. C.,
and Ames, B. N.
(1988)
J. Bacteriol.
170,
2344-2351
|
| 19.
|
Peterkofsky, A.,
and Lipsett, M. N.
(1965)
Biochem. Biophys. Res. Commun.
20,
780-786
|
| 20.
|
Abrell, J. W.,
Kaufman, D. E.,
and Lipsett, M. N.
(1971)
J. Biol. Chem.
246,
294-301
|
| 21.
|
Lipsett, M. N.
(1972)
J. Biol. Chem.
247,
1458-1461
|
| 22.
|
Ryals, J.,
Hsu, R.-Y.,
Lipsett, M. N.,
and Bremer, H.
(1982)
J. Bacteriol.
151,
899-904
|
| 23.
|
Thomas, G.,
and Favre, A.
(1977)
C. R. Seances Acad. Sci. Ser. D
284,
1345-1347
|
| 24.
|
Lipsett, M. N.
(1978)
J. Bacteriol.
135,
993-997
|
| 25.
|
Mueller, E. G.,
Buck, C. J.,
Palenchar, P. M.,
Barnhart, L. E.,
and Paulson, J. L.
(1998)
Nucleic Acids Res.
26,
2606-2610
|
| 26.
|
Webb, E.,
Claas, K.,
and Downs, D. M.
(1997)
J. Bacteriol.
179,
4399-4402
|
| 27.
|
Kambampati, R.,
and Lauhon, C. T.
(1999)
Biochemistry
38,
16561-16568
|
| 28.
|
Lauhon, C. T.,
and Kambampati, R.
(2000)
J. Biol. Chem.
275,
20096-20103
|
| 29.
|
Flint, D. H.
(1996)
J. Biol. Chem.
271,
16068-16074
|
| 30.
|
Zheng, L. M.,
White, R. H.,
Cash, V. L.,
and Dean, D. R.
(1994)
Biochemistry
33,
4714-4720
|
| 31.
|
Palenchar, P. M.,
Buck, C. J.,
Cheng, H.,
Larson, T. J.,
and Mueller, E. G.
(2000)
J. Biol. Chem.
275,
8283-8286
|
| 32.
|
Kambampati, R.,
and Lauhon, C. T.
(2000)
J. Biol. Chem.
275,
10727-10730
|
| 33.
|
Taylor, S. V.,
Kelleher, N. L.,
Kinsland, C.,
Chiu, H. J.,
Costello, C. K.,
Backstrom, A. D.,
McLafferty, F. W.,
and Begley, T. P.
(1998)
J. Biol. Chem.
273,
16555-16560
|
| 34.
|
Ramamurthy, V.,
Swann, S. L.,
Paulson, J. L.,
Spedaliere, C. J.,
and Mueller, E. G.
(1999)
J. Biol. Chem.
274,
22225-22230
|
| 35.
|
Mueller, E. G.,
and Palenchar, P. M.
(1999)
Protein Sci.
8,
2424-2427
|
| 36.
|
Gehrke, C. W.,
Kuo, K. C.,
McCune, R. A.,
Gerhardt, K. O.,
and Agris, P. F.
(1982)
J. Chromatogr.
230,
297-308
|
| 37.
|
Buck, M.,
Connick, M.,
and Ames, B. N.
(1983)
Anal. Biochem.
129,
1-13
|
| 38.
|
Dawson, R. M. C.,
Elliott, D. C.,
Elliott, W. H.,
and Jones, K. M.
(1986)
Data for Biochemical Research
, 3rd Ed.
, p. 388, Oxford Science Publications, Oxford
|
| 39.
|
Siegele, D. A.,
and Hu, J. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8168-8172
|
| 40.
|
Xi, J.,
Ge, Y.,
Kinsland, C.,
McLafferty, F. W.,
and Begley, T. P.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8513-8518
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Tanaka, S. Yamagata, Y. Kitago, Y. Yamada, S. Chimnaronk, M. Yao, and I. Tanaka
Deduced RNA binding mechanism of ThiI based on structural and binding analyses of a minimal RNA ligand
RNA,
August 1, 2009;
15(8):
1498 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Kouri, N. E. Labrou, S. D. Garbis, K. I. Kalliampakou, C. Stedel, M. Dimou, M. K. Udvardi, P. Katinakis, and E. Flemetakis
Molecular and Biochemical Characterization of the Parvulin-Type PPIases in Lotus japonicus
Plant Physiology,
July 1, 2009;
150(3):
1160 - 1173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nakai, M. Nakai, R. Lill, T. Suzuki, and H. Hayashi
Thio Modification of Yeast Cytosolic tRNA Is an Iron-Sulfur Protein-Dependent Pathway
Mol. Cell. Biol.,
April 15, 2007;
27(8):
2841 - 2847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Lundgren and G. R. Bjork
Structural Alterations of the Cysteine Desulfurase IscS of Salmonella enterica Serovar Typhimurium Reveal Substrate Specificity of IscS in tRNA Thiolation.
J. Bacteriol.,
April 1, 2006;
188(8):
3052 - 3062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shigi, T. Suzuki, T. Terada, M. Shirouzu, S. Yokoyama, and K. Watanabe
Temperature-dependent Biosynthesis of 2-Thioribothymidine of Thermus thermophilus tRNA
J. Biol. Chem.,
January 27, 2006;
281(4):
2104 - 2113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gabant, S. Auxilien, I. Tuszynska, M. Locard, M. J. Gajda, G. Chaussinand, B. Fernandez, A. Dedieu, H. Grosjean, B. Golinelli-Pimpaneau, et al.
THUMP from archaeal tRNA:m22G10 methyltransferase, a genuine autonomously folding domain.
Nucleic Acids Res.,
January 1, 2006;
34(9):
2483 - 2494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pierrel, T. Douki, M. Fontecave, and M. Atta
MiaB Protein Is a Bifunctional Radical-S-Adenosylmethionine Enzyme Involved in Thiolation and Methylation of tRNA
J. Biol. Chem.,
November 12, 2004;
279(46):
47555 - 47563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Armengaud, J. Urbonavicius, B. Fernandez, G. Chaussinand, J. M. Bujnicki, and H. Grosjean
N2-Methylation of Guanosine at Position 10 in tRNA Is Catalyzed by a THUMP Domain-containing, S-Adenosylmethionine-dependent Methyltransferase, Conserved in Archaea and Eukaryota
J. Biol. Chem.,
August 27, 2004;
279(35):
37142 - 37152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Lauhon, W. M. Erwin, and G. N. Ton
Substrate Specificity for 4-Thiouridine Modification in Escherichia coli
J. Biol. Chem.,
May 28, 2004;
279(22):
23022 - 23029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Lauhon, E. Skovran, H. D. Urbina, D. M. Downs, and L. E. Vickery
Substitutions in an Active Site Loop of Escherichia coli IscS Result in Specific Defects in Fe-S Cluster and Thionucleoside Biosynthesis in Vivo
J. Biol. Chem.,
May 7, 2004;
279(19):
19551 - 19558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Matthies, K. V. Rajagopalan, R. R. Mendel, and S. Leimkuhler
Evidence for the physiological role of a rhodanese-like protein for the biosynthesis of the molybdenum cofactor in humans
PNAS,
April 20, 2004;
101(16):
5946 - 5951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nakai, N. Umeda, T. Suzuki, M. Nakai, H. Hayashi, K. Watanabe, and H. Kagamiyama
Yeast Nfs1p Is Involved in Thio-modification of Both Mitochondrial and Cytoplasmic tRNAs
J. Biol. Chem.,
March 26, 2004;
279(13):
12363 - 12368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Leipuviene, Q. Qian, and G. R. Bjork
Formation of Thiolated Nucleosides Present in tRNA from Salmonella enterica serovar Typhimurium Occurs in Two Principally Distinct Pathways
J. Bacteriol.,
February 1, 2004;
186(3):
758 - 766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Wolfe, F. Ahmed, G. M. Lacourciere, C. T. Lauhon, T. C. Stadtman, and T. J. Larson
Functional Diversity of the Rhodanese Homology Domain: THE ESCHERICHIA COLI ybbB GENE ENCODES A SELENOPHOSPHATE-DEPENDENT tRNA 2-SELENOURIDINE SYNTHASE
J. Biol. Chem.,
January 16, 2004;
279(3):
1801 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Alphey, R. A. M. Williams, J. C. Mottram, G. H. Coombs, and W. N. Hunter
The Crystal Structure of Leishmania major 3-Mercaptopyruvate Sulfurtransferase: A THREE-DOMAIN ARCHITECTURE WITH A SERINE PROTEASE-LIKE TRIAD AT THE ACTIVE SITE
J. Biol. Chem.,
November 28, 2003;
278(48):
48219 - 48227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pierrel, H. L. Hernandez, M. K. Johnson, M. Fontecave, and M. Atta
MiaB Protein from Thermotoga maritima: CHARACTERIZATION OF AN EXTREMELY THERMOPHILIC tRNA-METHYLTHIOTRANSFERASE
J. Biol. Chem.,
August 8, 2003;
278(32):
29515 - 29524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Forlani, A. Carpen, and S. Pagani
Evidence that elongation of the catalytic loop of the Azotobacter vinelandii rhodanese changed selectivity from sulfur- to phosphate-containing substrates
Protein Eng. Des. Sel.,
July 1, 2003;
16(7):
515 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. M. Williams, S. M. Kelly, J. C. Mottram, and G. H. Coombs
3-Mercaptopyruvate Sulfurtransferase of Leishmania Contains an Unusual C-terminal Extension and Is Involved in Thioredoxin and Antioxidant Metabolism
J. Biol. Chem.,
January 10, 2003;
278(3):
1480 - 1486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Lauhon
Requirement for IscS in Biosynthesis of All Thionucleosides in Escherichia coli
J. Bacteriol.,
December 15, 2002;
184(24):
6820 - 6829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mihara, S.-i. Kato, G. M. Lacourciere, T. C. Stadtman, R. A. J. D. Kennedy, T. Kurihara, U. Tokumoto, Y. Takahashi, and N. Esaki
The iscS gene is essential for the biosynthesis of 2-selenouridine in tRNA and the selenocysteine-containing formate dehydrogenase H
PNAS,
May 14, 2002;
99(10):
6679 - 6683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pierrel, G. R. Bjork, M. Fontecave, and M. Atta
Enzymatic Modification of tRNAs. MiaB IS AN IRON-SULFUR PROTEIN
J. Biol. Chem.,
April 12, 2002;
277(16):
13367 - 13370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Frazzon and D. R. Dean
Feedback regulation of iron-sulfur cluster biosynthesis
PNAS,
December 18, 2001;
98(26):
14751 - 14753.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Urbina, J. J. Silberg, K. G. Hoff, and L. E. Vickery
Transfer of Sulfur from IscS to IscU during Fe/S Cluster Assembly
J. Biol. Chem.,
November 21, 2001;
276(48):
44521 - 44526.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|